Neurofibromatosis type 1, known as NF1, affects approximately 1 in 2,500 people. Coffee found to have startling effect on aging, says new study He was fooling around on the edge - then his hand ...

VICTORIA — An urban planning expert says a plan to convert empty condominiums into affordable housing in British Columbia might be more about stabilizing the financial sector than housing. Some have ...

All higher education institutions in Uttar Pradesh, including medical and dental colleges, are gearing up to set up “Dharmantaran Roktham Cells” (anti-conversion cells) following an order by state ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Convert a chunk of a traditional IRA to a Roth in your ...

Welcome to the Runner’s World Guide to Running Form, where we understand there’s no single “perfect” way to run. Rather than prescribing one ideal technique, this program introduces different types of ...

Researchers at Cincinnati Children's have identified a potential new way to relieve chronic pain linked to neurofibromatosis type 1 (NF1), a genetic condition best known for causing tumors to grow ...

UC San Francisco scientists ushered in the era of type 1 diabetes prevention, nearly 40 years ago. Now, they’re working to solve the biggest challenges standing between patients and functional cures ...

The first-ever clinical trial of an adeno-associated virus (AAV) gene therapy for type 1 diabetes (T1D) is set to begin this year. The PROGRESS study will enroll adults with T1D to receive a one-time ...

• Major opinion: The Supreme Court ruled against Colorado’s “conversion therapy” ban for gay and transgender youth on Tuesday. • Law remains: The decision technically does not strike down the law, ...

Four new tax deductions are available on federal returns for eligible taxpayers whether they itemize deductions, such as claiming mortgage interest, or claim the standard deduction. All four big tax ...

Seatrium has been awarded a contract by Karpowership for the conversion of a new floating storage regasification unit (FSRU). Scheduled to commence in the third quarter of 2026, the LNG carrier ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD). The ...